2000 - Fellow of the American Association for the Advancement of Science (AAAS)
Internal medicine, Disease, Wilson's disease, Zinc and Endocrinology are his primary areas of study. Internal medicine and Gastroenterology are frequently intertwined in his study. His biological study spans a wide range of topics, including Cancer, Copper deficiency, Copper toxicity, Toxicity and Immunology.
His Wilson's disease research integrates issues from Penicillamine, Chorea, Initial therapy, Dystonia and Copper metabolism. His Zinc study combines topics from a wide range of disciplines, such as Nuclear chemistry, Inorganic chemistry, Absorption, Intestinal absorption and Hypocupremia. He combines subjects such as Interleukin, Zinc deficiency and Copper with his study of Endocrinology.
George J. Brewer mainly investigates Internal medicine, Endocrinology, Wilson's disease, Zinc and Disease. The various areas that he examines in his Internal medicine study include Gastroenterology, Biochemistry and Copper. His Endocrinology research incorporates themes from Red Cell and Anemia.
His study in Wilson's disease is interdisciplinary in nature, drawing from both Surgery, Penicillamine, Maintenance therapy and Pediatrics. His Zinc study frequently links to adjacent areas such as Sickle cell anemia. George J. Brewer has researched Disease in several fields, including Copper toxicity, Immunology, Liver disease, Ingestion and Physiology.
George J. Brewer mostly deals with Disease, Internal medicine, Copper, Endocrinology and Copper toxicity. His specific area of interest is Disease, where George J. Brewer studies Wilson's disease. His research investigates the connection between Wilson's disease and topics such as Penicillamine that intersect with issues in Pediatrics and Double blind.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Zinc deficiency. His Copper research is multidisciplinary, incorporating perspectives in Zinc, Biochemistry, Toxicity and Bioinformatics. George J. Brewer has included themes like Diabetes mellitus and Alzheimer's disease in his Copper toxicity study.
His scientific interests lie mostly in Disease, Copper toxicity, Copper, Internal medicine and Endocrinology. The concepts of his Disease study are interwoven with issues in Toxicity, Pediatrics, Immunology and Surgery. His Copper toxicity research is multidisciplinary, relying on both Gerontology, Diabetes mellitus, Zinc, Physiology and Risk factor.
He interconnects XIAP, Pathology, Wilson's disease, Ceruloplasmin and Ingestion in the investigation of issues within Copper. His Wilson's disease study combines topics in areas such as Caspase 3, Biochemistry, MEDLINE and Copper metabolism. His Internal medicine research includes elements of Gastroenterology and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans
Frances W.J. Beck;Ananda S. Prasad;Joseph Kaplan;James T. Fitzgerald.
American Journal of Physiology-endocrinology and Metabolism (1997)
Hypocupremia induced by zinc therapy in adults.
Ananda S. Prasad;George J. Brewer;Eric B. Schoomaker;Parviz Rabbani.
JAMA (1978)
Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.
Quintin Pan;Celina G. Kleer;Kenneth L. Van Golen;Jennifer Irani.
Cancer Research (2002)
Serum thymulin in human zinc deficiency
A S Prasad;S Meftah;J Abdallah;J Kaplan.
Journal of Clinical Investigation (1988)
Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy.
George J. Brewer;Carol A. Terry;Alex M. Aisen;Gretchen M. Hill.
JAMA Neurology (1987)
Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study
George J. Brewer;Robert D. Dick;Damanjit K. Grover;Virginia LeClaire.
Clinical Cancer Research (2000)
Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance.
Alvin R. Tarlov;George J. Brewer;Paul E. Carson;Alf S. Alving.
JAMA Internal Medicine (1962)
Oral zinc therapy for Wilson's disease.
George J. Brewer;Gretchen M. Hill;Ananda S. Prasad;Zafrallah T. Cossack.
Annals of Internal Medicine (1983)
Risks of copper and iron toxicity during aging in humans.
George J. Brewer.
Chemical Research in Toxicology (2010)
Treatment of wilson disease with ammonium tetrathiomolybdate. IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of wilson disease
George J. Brewer;Fred Askari;Matthew T. Lorincz;Martha Carlson.
JAMA Neurology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Wayne State University
University of Michigan–Ann Arbor
University of Louisville
Michigan State University
University of Michigan–Ann Arbor
University of Michigan–Ann Arbor
Harvard Medical School
Washington University in St. Louis
Harvard University
University of Miami
University of Warwick
University of Alabama
Sungkyunkwan University
École Polytechnique Fédérale de Lausanne
Czech Academy of Sciences
Eastern Virginia Medical School
National Institutes of Health
Northwestern University
Federal University of Toulouse Midi-Pyrénées
Arizona State University
University of Pennsylvania
University of Eastern Finland
Johns Hopkins University
Medical College of Wisconsin
University of Colorado Anschutz Medical Campus
University of California, Santa Cruz